Drug Shortage Report for SOFLAX

Last updated on 2019-03-28 History
Report ID 38914
Drug Identification Number 02029529
Brand name SOFLAX
Common or Proper name SOFLAX
Company Name PHARMASCIENCE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DOCUSATE SODIUM
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code A06AA
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-02
Estimated end date 2019-03-05
Actual end date 2019-03-25
Shortage status Resolved
Updated date 2019-03-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2019-03-28 French Compare
v23 2019-03-28 English Compare
v22 2019-02-26 French Compare
v21 2019-02-26 English Compare
v20 2019-02-08 French Compare
v19 2019-02-08 English Compare
v18 2018-08-24 French Compare
v17 2018-08-24 English Compare
v16 2018-07-13 French Compare
v15 2018-07-13 English Compare
v14 2018-06-06 French Compare
v13 2018-06-06 English Compare
v12 2018-05-18 French Compare
v11 2018-05-18 English Compare
v10 2018-05-04 French Compare
v9 2018-05-04 English Compare
v8 2018-04-19 French Compare
v7 2018-04-19 English Compare
v6 2018-03-19 French Compare
v5 2018-03-19 English Compare

Showing 1 to 20 of 24